Coagulation tests: PT/INR, aPTT, fibrinogen and D-dimer

What it is

Routine coagulation tests measure, in a citrated plasma sample, how long it takes to form a clot once clotting is triggered in the laboratory. The prothrombin time (PT) tests the extrinsic and common pathways: factor VII, then factors X, V, II (prothrombin) and fibrinogen. Because the PT varies with the reagent, it is reported for vitamin K antagonists such as warfarin as the international normalised ratio (INR). The activated partial thromboplastin time (aPTT) tests the intrinsic and common pathways: factors XII, XI, IX and VIII, then the common factors; it is prolonged by unfractionated heparin and is used to look for haemophilia and lupus anticoagulant. Fibrinogen is the substrate of the final step and falls in consumption (DIC), severe liver disease and massive bleeding. D-dimer is a breakdown product of cross-linked fibrin: it rises whenever clot is formed and broken down, so it is sensitive but not specific, and its main use is to rule out venous thromboembolism when clinical probability is low. These tests do not measure platelet function or the whole clotting process in the body, so normal results do not rule out a bleeding disorder. Read them with the platelet count, the drugs the patient takes and the clinical picture, and remember that the sample itself (an under-filled tube, heparin from a line) causes many abnormal results.

Reference values and concepts

• PT about 11–13.5 seconds; INR about 0.8–1.2 without anticoagulants (ranges vary by laboratory and reagent).
• Usual INR target for most warfarin indications 2.0–3.0; higher for some mechanical heart valves.
• aPTT about 25–35 seconds (varies widely by laboratory); thrombin time is prolonged by heparin, dabigatran and low or abnormal fibrinogen.
• Fibrinogen about 200–400 mg/dL (2–4 g/L); it rises as an acute-phase protein and in pregnancy.
• D-dimer: below the laboratory cut-off is normal; many centres use an age-adjusted cut-off after 50 years (age × 10 µg/L FEU).
• Low molecular weight heparin and direct factor Xa inhibitors are measured with a calibrated anti-factor Xa assay, not reliably with the PT or aPTT.

Reading it step by step

1. Know the question first: bleeding, before a procedure, anticoagulant monitoring or suspected clot — it decides which tests matter.
2. Check the sample: a filled citrate tube, no clots, not drawn from a heparinised line — preanalytical errors cause many abnormal results.
3. Check drugs: warfarin, heparins, direct oral anticoagulants, antiplatelets — most abnormal results in hospital are drug effects.
4. Read PT/INR, then aPTT — the combination localises the problem to the extrinsic, intrinsic or common pathway.
5. Read fibrinogen and the platelet count with them — low values together suggest consumption or dilution.
6. If one time is long without an obvious cause, ask for a mixing study — correction means deficiency, no correction an inhibitor.
7. Read D-dimer only after estimating clinical probability — it is useful to rule out a clot when probability is low or intermediate.
8. Normal tests with a bleeding history: think of platelets, von Willebrand disease and vessels — routine tests miss them.

Reading the combination

Patterns and common mistakes

• Long PT, normal aPTT: vitamin K antagonist, early vitamin K deficiency, early liver disease, or factor VII deficiency.
• Long aPTT, normal PT: unfractionated heparin, haemophilia A or B, factor XI deficiency, some von Willebrand disease, lupus anticoagulant, or factor XII deficiency (which does not bleed).
• Both long: common pathway problem, DIC, severe liver disease, marked vitamin K deficiency or warfarin excess, dilution after massive transfusion.
• Lupus anticoagulant prolongs the aPTT in the tube but causes thrombosis, not bleeding, in the patient.
• Common mistakes: a falsely long time from an under-filled tube or high haematocrit, sampling above a heparin infusion, using PT or aPTT to judge apixaban or rivaroxaban levels.
• Liver disease prolongs the INR, but this does not mean the patient is protected from thrombosis.

Next step

• Repeat any unexpected result from a fresh, correctly filled sample drawn by a clean venepuncture before acting on it.
• High INR on warfarin: hold or adjust it per protocol; with major bleeding, call a senior for reversal with vitamin K and prothrombin complex concentrate.
• Suspected DIC: treat the cause, repeat platelets, PT, aPTT, fibrinogen and D-dimer, and involve the senior and haematology team.
• Unexplained isolated long aPTT before surgery: ask for a mixing study and factor levels, and delay elective procedures until explained.
• Positive D-dimer with suspected thrombosis: arrange imaging (compression ultrasound or CT pulmonary angiography) as the pathway says.

Test yourself

Think of the answer, then tap the question to see it.

Add to my cards (4)

Elsewhere in DurgiPedia

• The coagulation cascade
• Coagulation tests: PT/INR, aPTT and platelets
• Primary hemostasis and platelets
• Fibrinolysis and natural anticoagulants
• Acquired coagulation factor disorders
• Vitamin K (phylloquinone)

Connections

← All clinical skills

Educational content; it does not replace supervised hands-on training, your institution's protocols or a prescriber's order. A procedure is learnt with a teacher and done only once you are trained to do it.

Sources: Interpretation of Blood Clotting Studies and Values (PT, PTT, aPTT, INR, Anti-Factor Xa, D-Dimer) (StatPearls (NCBI Bookshelf), 2025); Prothrombin Time (StatPearls (NCBI Bookshelf), 2026); Partial Thromboplastin Time (StatPearls (NCBI Bookshelf), 2023).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Send

Representative model, for educational purposes only.